ARWR
Arrowhead Pharmaceuticals Inc
Price:  
16.76 
USD
Volume:  
3,012,536.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ARWR Relative Valuation

-220.5%
Upside

As of 2025-07-19, the Relative Valuation of Arrowhead Pharmaceuticals Inc (ARWR) is (20.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 16.76 USD, the upside of Arrowhead Pharmaceuticals Inc based on Relative Valuation is -220.5%.

The range of the Relative Valuation is (15.74) - (25.33) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 15.1x - 24.3x 19.6x
Forward P/E multiples 13.1x - 24.8x 19.2x
Fair Price (15.74) - (25.33) (20.20)
Upside -193.9% - -251.1% -220.5%
16.76 USD
Stock Price
(20.20) USD
Fair Price

ARWR Relative Valuation - Historical P/E Data

Date P/E
2025-07-18 -16.08
2025-07-17 -18.08
2025-07-16 -17.55
2025-07-15 -16.91
2025-07-14 -17.85
2025-07-11 -17.56
2025-07-10 -18.09
2025-07-09 -18.11
2025-07-08 -16.82
2025-07-07 -16.15
2025-07-03 -16.11
2025-07-02 -16.21
2025-07-01 -15.43
2025-06-30 -15.16
2025-06-27 -15.42
2025-06-26 -15.41
2025-06-25 -15.02
2025-06-24 -15.31
2025-06-23 -14.88
2025-06-20 -14.70
2025-06-18 -14.98
2025-06-17 -14.87
2025-06-16 -15.06
2025-06-13 -15.10
2025-06-12 -15.56
2025-06-11 -16.06
2025-06-10 -16.28
2025-06-09 -15.89
2025-06-06 -16.12
2025-06-05 -15.79
2025-06-04 -16.06
2025-06-03 -15.93
2025-06-02 -15.73
2025-05-30 -15.41
2025-05-29 -16.13
2025-05-28 -14.93
2025-05-27 -14.74
2025-05-23 -14.51
2025-05-22 -14.76
2025-05-21 -14.69
2025-05-20 -15.63
2025-05-19 -15.10
2025-05-16 -15.07
2025-05-15 -14.71
2025-05-14 -14.30
2025-05-13 -14.66
2025-05-12 -13.40
2025-05-09 -12.50
2025-05-08 -12.71
2025-05-07 -12.53